Literature DB >> 12742581

Delineation of the regulated Variant Surface Glycoprotein gene expression site domain of Trypanosoma brucei.

Karen Sheader1, Magali Berberof, Tomoko Isobe, Piet Borst, Gloria Rudenko.   

Abstract

The African trypanosome Trypanosoma brucei is protected in the bloodstream of the mammalian host by a dense Variant Surface Glycoprotein (VSG) coat. Although an individual cell has hundreds of VSG genes, the active VSG is transcribed in a mutually exclusive fashion from one of about twenty telomeric VSG expression sites. Expression sites are regulated domains flanked by 50 bp repeat arrays and extensive tracts of repetitive elements. We have integrated exogenous rDNA and expression site promoters upstream of the 50 bp repeats of the VO2 VSG expression site. Transcription from both types of exogenous promoter is downregulated and comparable to promoters targeted into the VSG Basic Copy arrays. We show that the upstream exogenous rDNA promoter escapes VSG expression site control, as switching the downstream VO2 VSG expression site on and off does not affect its activity. Therefore, the 50 bp repeat arrays appear to be the boundary of the regulated expression site domain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12742581     DOI: 10.1016/s0166-6851(03)00056-2

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  9 in total

1.  Biological variation among african trypanosomes: I. Clonal expression of virulence is not linked to the variant surface glycoprotein or the variant surface glycoprotein gene telomeric expression site.

Authors:  Jill A Inverso; Timothy S Uphoff; Scott C Johnson; Donna M Paulnock; John M Mansfield
Journal:  DNA Cell Biol       Date:  2010-05       Impact factor: 3.311

Review 2.  The central roles of telomeres and subtelomeres in antigenic variation in African trypanosomes.

Authors:  David Horn; J David Barry
Journal:  Chromosome Res       Date:  2005       Impact factor: 5.239

3.  TbISWI regulates multiple polymerase I (Pol I)-transcribed loci and is present at Pol II transcription boundaries in Trypanosoma brucei.

Authors:  Tara M Stanne; Manish Kushwaha; Matthew Wand; Jesse E Taylor; Gloria Rudenko
Journal:  Eukaryot Cell       Date:  2011-05-13

Review 4.  The epigenome of Trypanosoma brucei: a regulatory interface to an unconventional transcriptional machine.

Authors:  Johannes P Maree; Hugh-G Patterton
Journal:  Biochim Biophys Acta       Date:  2014-06-03

5.  Active VSG expression sites in Trypanosoma brucei are depleted of nucleosomes.

Authors:  Tara M Stanne; Gloria Rudenko
Journal:  Eukaryot Cell       Date:  2009-11-13

6.  Dynamic colocalization of 2 simultaneously active VSG expression sites within a single expression-site body in Trypanosoma brucei.

Authors:  James Budzak; Louise E Kerry; Aris Aristodemou; Belinda S Hall; Kathrin Witmer; Manish Kushwaha; Carys Davies; Megan L Povelones; Jacquelyn R McDonald; Aakash Sur; Peter J Myler; Gloria Rudenko
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-29       Impact factor: 11.205

7.  TbSAP is a novel chromatin protein repressing metacyclic variant surface glycoprotein expression sites in bloodstream form Trypanosoma brucei.

Authors:  Carys Davies; Cher-Pheng Ooi; Georgios Sioutas; Belinda S Hall; Haneesh Sidhu; Falk Butter; Sam Alsford; Bill Wickstead; Gloria Rudenko
Journal:  Nucleic Acids Res       Date:  2021-04-06       Impact factor: 16.971

8.  Stage-specific transcription activator ESB1 regulates monoallelic antigen expression in Trypanosoma brucei.

Authors:  Lara López-Escobar; Benjamin Hänisch; Clare Halliday; Midori Ishii; Bungo Akiyoshi; Samuel Dean; Jack Daniel Sunter; Richard John Wheeler; Keith Gull
Journal:  Nat Microbiol       Date:  2022-07-25       Impact factor: 30.964

9.  Cohesin regulates VSG monoallelic expression in trypanosomes.

Authors:  David Landeira; Jean-Mathieu Bart; Daria Van Tyne; Miguel Navarro
Journal:  J Cell Biol       Date:  2009-07-27       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.